by Sue Robbins | Nov 27, 2019 | Migraine
Ergotamine has historically been used to treat migraine since the middle ages, and as a pharmaceutical since 1926,1 but is limited by poor tolerability (nausea, vomiting, and cardiovascular effects), thus attempts were made to synthesize compounds with the same...
by Sue Robbins | Nov 25, 2019 | Migraine
Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology. The study, published online recently in the Journal of...
by Sue Robbins | Nov 22, 2019 | Migraine
Vestibular migraine (VM) differs from migraine without vestibular symptoms in regard to mild and low frequency roll tilt (of the head) perceptual thresholds, a study in Science Reports suggests. The study enrolled patients with VM, measuring the frequency-dependence...
by Sue Robbins | Nov 20, 2019 | Migraine
Intranasal lidocaine may be a useful option for patients with an acute migraine, according to a study which showed the drug had a high success rate, low pain intensity, infrequent need for rescue medicine, and tolerable adverse events. The research, published by PLOS...
by Sue Robbins | Nov 19, 2019 | Migraine
Migraine sufferers who used a smartphone-based relaxation technique at least twice a week experienced on average four fewer headache days per month, a new study shows. Developed in part by researchers at NYU School of Medicine, the app, called RELAXaHEAD, guides...
